Rhythm Pharmaceuticals, Inc. (RYTM)
NASDAQ: RYTM · Real-Time Price · USD
59.93
-0.25 (-0.42%)
At close: May 16, 2025, 4:00 PM
59.70
-0.23 (-0.38%)
After-hours: May 16, 2025, 4:51 PM EDT
Rhythm Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 12 professional analysts, the 12-month price target for Rhythm Pharmaceuticals stock ranges from a low of $65 to a high of $92. The average analyst price target of $75.42 forecasts a 25.85% increase in the stock price over the next year.
Price Target: $75.42 (+25.85%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Rhythm Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 7 | 8 | 8 |
| Buy | 3 | 3 | 3 | 4 | 4 | 4 |
| Hold | 1 | 1 | 1 | 1 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 10 | 12 | 12 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Strong Buy Maintains $66 → $72 | Strong Buy | Maintains | $66 → $72 | +20.14% | May 7, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $63 → $68 | Strong Buy | Maintains | $63 → $68 | +13.47% | Apr 10, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $70 → $80 | Strong Buy | Reiterates | $70 → $80 | +33.49% | Apr 8, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $81 → $92 | Strong Buy | Maintains | $81 → $92 | +53.51% | Apr 8, 2025 |
| Needham | Needham | Strong Buy Reiterates $66 | Strong Buy | Reiterates | $66 | +10.13% | Apr 8, 2025 |
Financial Forecast
Revenue This Year
179.42M
from 130.13M
Increased by 37.88%
Revenue Next Year
310.11M
from 179.42M
Increased by 72.84%
EPS This Year
-2.68
from -4.34
EPS Next Year
-1.45
from -2.68
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 191.5M | 420.0M | 686.8M | ||
| Avg | 179.4M | 310.1M | 534.7M | ||
| Low | 166.6M | 226.8M | 295.0M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 47.1% | 134.1% | 121.5% | ||
| Avg | 37.9% | 72.8% | 72.4% | ||
| Low | 28.0% | 26.4% | -4.9% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -2.06 | -0.40 | 3.31 | ||
| Avg | -2.68 | -1.45 | 1.89 | ||
| Low | -3.09 | -2.38 | 1.01 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.